EMEA-001782-PIP01-15-M03

Key facts

Invented name
Influvac Tetra
Active substance
Influenza virus surface antigens (haemagglutinin and neuraminidase) of the following strains: A/(H1N1), A/(H3N2), B/Yamagata lineage, B/Victoria lineage
Therapeutic area
Vaccines
Decision number
P/0211/2018
PIP number
EMEA-001782-PIP01-15-M03
Pharmaceutical form(s)
Suspension for injection
Condition(s) / indication(s)
Prevention of influenza infection
Route(s) of administration
Intramuscular use
Contact for public enquiries
Abbott Biologicals B.V.
Tel. +41 6148 70374
Email: hind.ounis@abbott.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating